Mr. SahmAdrangi the Brains Behind Million Dollar Hedge Fund

Kerrisdale co-investment funds seem to be unique; it has managed to raise $100 million from investors to bet against a single stock. Most of the hedge manager use money rose for particular investments such as distressed recovery companies or mortgage-based securities. The company, however, plans to use their funds to short the stock of soon to be unveiled public company. The company which now manages $500 million has a reputation of betting against companies and taking the case public. Some of these cases include drug makers, sage therapeutics, Zagfen, and Globalstar. The hedge fund company is based in New York. The company bets for and against company stocks average annual returns of 28%.

SahmAdrangi involvement in the company goes all the way to 2009. He established the company with about $ 1 million, but now the company is worth $ 150 million. The company shares its dealings on social media, this is in a bid to correct the misconception about the organizations business prospects. The information includes published research, views on stock and overhyped shorts that are misunderstood by the market. The CEO came to light by exposing companies which were defrauding their way to the top, such as, China Biotic, Lihua international and many others which became subject to enforcement actions by the Securities and Exchange Commission.

While the company shares research, over the years, it developed an interest in other sectors such as the biotechnology sector. The company published research and development regarding the sector. The companies which are involved include Bavarian Nordic and Sage Therapeutics. The company also questioned the mining prospects and valuations of northern dynastic minerals and other resource companies. Consequently, it published various reports on the telecommunication sector. In the live presentation, he exposed the weakness in Globalstar proposed terrestrial low power services. In 2013 the company assisted the Lindsay corporation management to maximize the company’s cash strategies and capital allocation endeavors. Mr. Adrangi started his profession in performing high yield and leveraged loan debt financing at Deutsche bank and advising creditor committees on restructuring solutions. He graduated from Yale University with a bachelor’s degree in economics. He has also featured in numerous publications.